greeksoup/ stock research

Johnson & Johnson (JNJ) FY2017 results: revenue $76.5 billion, up 6.3% on the year

Johnson & Johnson (JNJ) reported revenue of $76.5 billion for fiscal 2017, the year ended 31 December 2017, up 6.3% on the year before. Net income was $1.3 billion, down 92.1%, and diluted earnings per share $0.47. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2019.

Revenue
$76.5 billion
+6.3% on the year
FY2010FY2017
Operating margin
n/a
FY2010FY2017
Net income
$1.3 billion
-92.1% on the year
FY2010FY2017
Diluted EPS
$0.47
-92.1% on the year
FY2010FY2017

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2017FY2016FY2015On the yearLast 8 years
Revenue76,45071,89070,074+6.3%
Cost of revenue25,43921,78921,536+16.8%
Gross profit51,09650,10148,538+2.0%
Gross margin66.8%69.7%69.3%
Research and development10,5949,1439,046+15.9%
Selling, general and administrative21,52020,06721,203+7.2%
Interest expense934726552+28.7%
Pre-tax income17,67319,80319,196-10.8%
Income tax16,3733,2633,787+401.8%
Effective tax rate92.6%16.5%19.7%
Net income1,30016,54015,409-92.1%
Net margin1.7%23.0%22.0%
Diluted EPS$0.47$5.93$5.48-92.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2017FY2016FY2015On the yearLast 8 years
Operating cash flow21,05618,76719,569+12.2%
Capital expenditure3,2793,2263,463+1.6%
Free cash flow17,77715,54116,106+14.4%
Free cash flow margin23.3%21.6%23.0%
Cash from investing-14,868-4,761-7,735
Cash from financing-7,673-8,551-11,136
Depreciation and amortisation5,6423,7543,746+50.3%
Share-based compensation962878874+9.6%
Buybacks6,3588,9795,290-29.2%
Dividends paid8,9438,6218,173+3.7%
Dividend per share$3.32$3.15$2.95+5.4%
Diluted shares, weighted2,745m2,789m2,813m-1.6%

Balance sheet

$ millionFY2017FY2016FY2015On the yearLast 8 years
Shareholders' equity60,16070,41871,150-14.6%
Debt34,58127,12619,861+27.5%
Other liabilities62,56243,66442,400+43.3%
Total liabilities and equity157,303141,208133,411+11.4%
Fixed assets17,00515,91215,905+6.9%
Goodwill31,90622,80521,629+39.9%
Intangible assets53,22826,87625,764+98.1%
Investments47222,93524,644-97.9%
Cash and equivalents17,82418,97213,732-6.1%
Receivables13,49011,69910,734+15.3%
Inventory8,7658,1448,053+7.6%
Other assets14,61313,86512,950+5.4%
Total assets157,303141,208133,411+11.4%

10-K for the year ended 31 December 2017, filed 20 February 2019: the filing.